Overall Technical outlook

Price Summary

On 2025-08-14, Piramal Pharma Limited's stock opened at 192.88, spiked to 193.79, declined to 189.55, and closed -1.47% down at 190.04, with 2043629 shares traded.
The peak price for the stock in the past 52 weeks is 293.55, with the lowest price being 182.08.
9 analysts predict that the future price of PPLPHARMA will be in the range of 230.0 to 305.0, with a mean expected price of about 256.66666.

Technicals

Support and Resistance: The price is currently at 190.04, supported by 190.75 and resisted by 190.75. This indicates a range where 190.75 may provide a base for the price, while 190.75 serves as a cap on further upward movement for PPLPHARMA.
PPLPHARMA supportResistance fca80f
Support/Resistance for PPLPHARMA


Aroon: The AROON is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
PPLPHARMA aroon fca80f
Aroon chart for Piramal Pharma Limited


Bol. Bands: The BOLL BANDS is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
PPLPHARMA bbands fca80f
Bolinger Bands chart for Piramal Pharma Limited


Parabolic SAR: The PSAR has shifted from bearish to bullish in its latest move, hinting at a possible trend reversal. If this change is corroborated by other indicators, it could represent a significant bullish signal. Traders should watch for additional confirmation to assess the strength of this potential upward trend for Piramal Pharma Limited.
PPLPHARMA psar fca80f
Parabolic Stop and Reverse chart for Piramal Pharma Limited


Stochastic: The STOCHASTIC is showing a neutral stance, with no definitive indication of an upward or downward trend for PPLPHARMA. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
PPLPHARMA stoch fca80f
Stochastic chart for Piramal Pharma Limited


Tripple Moving Agerage: The moving averages for the 20-50-100 periods indicate a bullish trend, though the slopes of the faster averages suggest that this trend may not last. The weakening signals from the shorter-term averages point to a potential reversal, indicating that the current upward momentum could be approaching a turning point.
PPLPHARMA trippleSMA fca80f
Tripple SMA chart for Piramal Pharma Limited


When evaluating a company's technical indicators like price trends and trading volume, it's important to also assess its fundamentals. Key factors include the company's profitability, growth rate, and financial stability. Furthermore, considering the industry within which the company operates provides additional context, as factors like competition and market demand can affect performance. By combining this analysis, you can make more informed judgments about the company's future prospects.